ATE463493T1 - Als antipilzmittel geeignete azolderivate mit reduzierter wechselwirkung mit metabolischen zytochromen - Google Patents

Als antipilzmittel geeignete azolderivate mit reduzierter wechselwirkung mit metabolischen zytochromen

Info

Publication number
ATE463493T1
ATE463493T1 AT04790506T AT04790506T ATE463493T1 AT E463493 T1 ATE463493 T1 AT E463493T1 AT 04790506 T AT04790506 T AT 04790506T AT 04790506 T AT04790506 T AT 04790506T AT E463493 T1 ATE463493 T1 AT E463493T1
Authority
AT
Austria
Prior art keywords
cytochromes
metabolic
fungal agent
azole derivatives
derivatives suitable
Prior art date
Application number
AT04790506T
Other languages
English (en)
Inventor
Massimo Pinori
Maria Lattanzio
Daniela Modena
Paolo Mascagni
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Application granted granted Critical
Publication of ATE463493T1 publication Critical patent/ATE463493T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT04790506T 2003-10-17 2004-10-14 Als antipilzmittel geeignete azolderivate mit reduzierter wechselwirkung mit metabolischen zytochromen ATE463493T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002020A ITMI20032020A1 (it) 2003-10-17 2003-10-17 Nuovi agenti antifungini azolici con diminuita interazione con i citocromi metabolici
PCT/EP2004/011667 WO2005040156A1 (en) 2003-10-17 2004-10-14 Azole derivative useful as antifungal agents with reduced interaction with metabolic cytochromes

Publications (1)

Publication Number Publication Date
ATE463493T1 true ATE463493T1 (de) 2010-04-15

Family

ID=34509451

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04790506T ATE463493T1 (de) 2003-10-17 2004-10-14 Als antipilzmittel geeignete azolderivate mit reduzierter wechselwirkung mit metabolischen zytochromen

Country Status (17)

Country Link
US (1) US7427620B2 (de)
EP (1) EP1673368B1 (de)
JP (1) JP4744446B2 (de)
KR (1) KR101182740B1 (de)
CN (1) CN1867565B (de)
AT (1) ATE463493T1 (de)
BR (1) BRPI0415319A (de)
CA (1) CA2542361C (de)
CY (1) CY1112166T1 (de)
DE (1) DE602004026457D1 (de)
DK (1) DK1673368T3 (de)
ES (1) ES2344703T3 (de)
IT (1) ITMI20032020A1 (de)
PL (1) PL1673368T3 (de)
PT (1) PT1673368E (de)
SI (1) SI1673368T1 (de)
WO (1) WO2005040156A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5963363B2 (ja) 2010-09-30 2016-08-03 国立大学法人 鹿児島大学 Auroraキナーゼプロモーターを含む増殖制御型ウイルスベクター

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3609596A1 (de) * 1986-03-21 1987-10-01 Hoechst Ag 2-azolylmethyl-2-aryl-1,3-dioxolane und deren salze, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung
EP0237693A1 (de) 1986-03-21 1987-09-23 Ambrogio Catracchia Düse zum Reinigen von Zähnen und zahnärztlichen Apparaten
US4788190A (en) * 1986-12-24 1988-11-29 Schering Corporation 2,4,4-tri- and 2,2,4,4-tetra substituted-1,3-dioxolane antifungal, antiallergy compounds
ZA9410142B (en) 1993-12-21 1996-05-02 Schering Corp Tetrahydrofuran antifungals
AU3483497A (en) 1996-06-28 1998-01-21 Schering Corporation Solid solution of an antifungal agent with enhanced bioavailability
EE03876B1 (et) 1997-02-11 2002-10-15 Janssen Pharmaceutica N.V. Aminohappe estrit sisaldavad asool-antimükootikumid, nende valmistamine ja kasutamine ning neid sisaldavad farmatseutilised kompositsioonid
EP0957101A1 (de) * 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Wasserlösliche Azole als Breitspektrum-antifungus
FR2807434B1 (fr) * 2000-04-05 2002-10-18 Hoechst Marion Roussel Inc Nouveaux derives de la 1,2,3,4-tetrahydroisoquinoleine, leur procede de preparation et leur application comme fongicides

Also Published As

Publication number Publication date
ITMI20032020A1 (it) 2005-04-18
EP1673368B1 (de) 2010-04-07
CN1867565B (zh) 2011-06-22
BRPI0415319A (pt) 2006-12-05
CY1112166T1 (el) 2015-12-09
WO2005040156A8 (en) 2005-06-23
JP4744446B2 (ja) 2011-08-10
KR20060130554A (ko) 2006-12-19
ES2344703T3 (es) 2010-09-03
PT1673368E (pt) 2010-07-09
US7427620B2 (en) 2008-09-23
PL1673368T3 (pl) 2010-09-30
CA2542361C (en) 2012-04-24
DE602004026457D1 (de) 2010-05-20
DK1673368T3 (da) 2010-06-07
JP2007533638A (ja) 2007-11-22
WO2005040156A1 (en) 2005-05-06
CN1867565A (zh) 2006-11-22
US20070129376A1 (en) 2007-06-07
KR101182740B1 (ko) 2012-09-13
EP1673368A1 (de) 2006-06-28
CA2542361A1 (en) 2005-05-06
SI1673368T1 (sl) 2010-08-31

Similar Documents

Publication Publication Date Title
JOP20220155A1 (ar) مشتقات البيرازول مفيدة كعوامل مضادة للسرطان
NO20072978L (no) Nye betuinderivater, preparat derav og anvendelse derav
MX2009008540A (es) Inhibidores de virus de hepatitis c macrociclicos sustituidos con pirimidina.
NO20073743L (no) Forbindelser med Kv4 ionekanal aktivitet
NO20066055L (no) Pyridinderivater
NO20080399L (no) Farmasoytiske sammensetninger for forlenget avgivelse, samt fremgangsmater for fremstilling derav
NO20073357L (no) 5-karboksamid substituerte tiazol derivater som reagerer med ionekanaler, i saerdeleshet med ionekanaler fra Kv familien
PA8591701A1 (es) Derivados de pirrolopirimidina
NO20085087L (no) Nye heterocykliske forbindelser
DOP2009000124A (es) Derivados de benzamida como receptores agonista ep4
AR066972A1 (es) Derivados azapeptidicos
SE0400284D0 (sv) Novel compounds
UA89040C2 (ru) Замещенные глюкопиранозилом бензольные производные, лекарственное средство, которое содержит эти соединения
TW200643013A (en) Pyrazoles
NO20025641D0 (no) Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister
ATE455103T1 (de) Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
NO20081001L (no) Derivater av karboksamid som antagonister for muskarinisk reseptor
NO20025640D0 (no) Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister
NO20064705L (no) Nye farmasoytiske preparater omfattende agonister av tyroidreseptoren
MX2022000598A (es) Preparacion de compuestos antibacterianos.
CL2003002565A1 (es) Compuestos derivados de 3h-quinazolin-4-ona, su proceso de preparacion, composicion farmaceutica que los contiene, y uso en el tratamiento y prevencion de enfermedades mediadas por inhibidores de mao-b, tales como la enfermedad de alzheimer y demenci
ATE490958T1 (de) Als agonisten für den nikotinischen acetylcholinrezeptor geeignete azabicycloalkanderivate
SE0401655D0 (sv) New compounds
CO2023000854A2 (es) Nuevo derivado de pirazol
TW200740795A (en) Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1673368

Country of ref document: EP